Skip to content
10-Q

Quarterly Report

TFF PHARMACEUTICALS, INC.

0001213900-24-100587

← back to feed
Filed
Nov 20, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 18, 2024 4.44M sh
Shares Diluted Q3 2024 · Sep 30, 2024 4.37M sh
Shares Diluted Q3 2024 · Sep 30, 2024 3.48M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.9M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 1.6M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$8.38M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$11.82M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $2.6M
Stockholders Equity Q3 2024 · Sep 30, 2024 $3.14M
Stockholders Equity Q3 2024 · Jun 30, 2024 $5.88M
Stockholders Equity Q3 2024 · Mar 31, 2024 $5.3M
Stockholders Equity Q3 2024 · Dec 31, 2023 $9.57M
Stockholders Equity Q3 2024 · Sep 30, 2023 $13.69M
Stockholders Equity Q3 2024 · Jun 30, 2023 $12.28M
Stockholders Equity Q3 2024 · Mar 31, 2023 $16.54M
Stockholders Equity Q3 2024 · Dec 31, 2022 $22.88M
Current Liabilities Q3 2024 · Sep 30, 2024 $3.94M
Current Liabilities Q3 2024 · Dec 31, 2023 $2.43M
Total Liabilities Q3 2024 · Sep 30, 2024 $3.94M
Total Liabilities Q3 2024 · Dec 31, 2023 $2.46M
Current Assets Q3 2024 · Sep 30, 2024 $3.51M
Current Assets Q3 2024 · Dec 31, 2023 $7.59M
Total Assets Q3 2024 · Sep 30, 2024 $7.08M
Total Assets Q3 2024 · Dec 31, 2023 $12.03M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.81
Eps Diluted Q3 2024 · Sep 30, 2024 −$3.95
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$2.32
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$10.30
Eps Basic Q3 2024 · Sep 30, 2024 −$0.81
Eps Basic Q3 2024 · Sep 30, 2024 −$3.95
Eps Basic restated Q3 2024 · Sep 30, 2023 −$2.32
Eps Basic restated Q3 2024 · Sep 30, 2023 −$10.30
Sga Expense Q3 2024 · Sep 30, 2024 $2.08M
Sga Expense Q3 2024 · Sep 30, 2024 $6.54M
Sga Expense Q3 2024 · Sep 30, 2023 $2.27M
Sga Expense Q3 2024 · Sep 30, 2023 $8.06M
Rd Expense Q3 2024 · Sep 30, 2024 $1.69M
Rd Expense Q3 2024 · Sep 30, 2024 $7.84M
Rd Expense Q3 2024 · Sep 30, 2023 $2.39M
Rd Expense Q3 2024 · Sep 30, 2023 $9.09M
Net Income Q3 2024 · Sep 30, 2024 −$3.54M
Net Income Q3 2024 · Sep 30, 2024 −$13.76M
Net Income Q3 2024 · Jun 30, 2024 −$4.48M
Net Income Q3 2024 · Mar 31, 2024 −$5.74M
Net Income Q3 2024 · Sep 30, 2023 −$4.41M
Net Income Q3 2024 · Sep 30, 2023 −$16.48M
Net Income Q3 2024 · Jun 30, 2023 −$5.02M
Net Income Q3 2024 · Mar 31, 2023 −$7.05M
Operating Income Q3 2024 · Sep 30, 2024 −$3.58M
Operating Income Q3 2024 · Sep 30, 2024 −$13.34M
Operating Income Q3 2024 · Sep 30, 2023 −$4.42M
Operating Income Q3 2024 · Sep 30, 2023 −$16.53M
Revenue Q3 2024 · Sep 30, 2024 $193.39K
Revenue Q3 2024 · Sep 30, 2024 $1.05M
Revenue Q3 2024 · Sep 30, 2023 $234.76K
Revenue Q3 2024 · Sep 30, 2023 $619.54K
Capex Q3 2024 · Sep 30, 2023 $48.36K